Journal of Clinical Pathology
Overview
The Journal of Clinical Pathology is a peer-reviewed medical journal that focuses on the study and diagnosis of diseases through laboratory testing and pathological analysis. It publishes original research articles, case reports, and reviews, covering a wide range of topics in clinical pathology, including molecular diagnostics, immunology, hematology, microbiology, and cytology. The journal serves as a valuable resource for healthcare professionals, researchers, and pathologists seeking to advance their knowledge and understanding of clinical pathology.
Details
Details
Abbr.
J Clin Pathol
Start
1947
End
Continuing
Frequency
Monthly
p-ISSN
0021-9746
e-ISSN
1472-4146
Country
United Kingdom
Language
English
Specialty
Pathology
Metrics
Metrics
h-index / Ranks: 1356
153
SJR / Ranks: 4256
934
CiteScore / Ranks: 2299
7.90
JIF / Ranks: 2884
3.4
Recent Articles
1.
Egevad L, Micoli C, Delahunt B, Samaratunga H, Garmo H, Stattin P, et al.
J Clin Pathol
. 2025 Mar;
PMID: 40081884
Reporting of prostate cancer grade has drifted to higher reported grades over the past decades. In prostate cancers diagnosed on needle biopsy of 1 72 112 men reported to The...
2.
Carcinoma arising in microglandular adenosis of the breast: clinicopathological and genetic analysis
Zhang Q, Li Y, Yu B, Bi R, Xu X, Cheng Y, et al.
J Clin Pathol
. 2025 Mar;
PMID: 40081883
Aims: To study the clinicopathological, immunohistochemical and molecular features of carcinoma arising in microglandular adenosis (MGACA) of the breast. Methods: Clinicopathological features of 13 cases of MGACA were analysed. All...
3.
Pineda C, OLoughlin L, Benjamin H, Rangachari D, Viray H, Widick P, et al.
J Clin Pathol
. 2025 Mar;
PMID: 40081882
Aims: Fam-trastuzumab deruxtecan-nxki (T-DXd) was recently approved for advanced stage or metastatic solid tumours with human epidermal growth factor receptor 2 (HER2) immunohistochemical (IHC) 3+ staining. Data on HER2 IHC...
4.
5.
Taha S, Boulos F
J Clin Pathol
. 2025 Mar;
PMID: 40044421
The concept of extensive intraductal component (EIC), currently defined by the presence of a prominent ductal carcinoma in situ (DCIS) component within an invasive tumor and extending beyond its margins,...
6.
Nelan R, Mijuskovic M, Hughes M, Becq J, Kingsbury Z, Tsogka E, et al.
J Clin Pathol
. 2025 Mar;
PMID: 40032506
Aims: Whole-genome sequencing (WGS) is beginning to be applied to cancer samples in the clinical setting. This ideally requires high-quality, minimally degraded DNA of high tumour cell content, while retaining...
7.
Ranot J, Noghani P, Rothwell D, Wasserman J
J Clin Pathol
. 2025 Feb;
PMID: 40015956
Aims: Patients of The Ottawa Hospital (TOH) are given immediate access to their pathology reports via an online patient portal. The purpose of this study was to determine how often...
8.
Attygalle A, Karube K, Jeon Y, Cheuk W, Bhagat G, Chan J, et al.
J Clin Pathol
. 2025 Feb;
PMID: 39965886
The fifth edition of the WHO Classification of Haematolymphoid Tumors (WHO-HAEM5) introduces significant advancements in the understanding and diagnosis of mature T cell and NK cell, and stroma-derived neoplasms, and...
9.
Kiraz U, Rewcastle E, Pettersen K, Abono D, Raghe S, Gudlaugsson E, et al.
J Clin Pathol
. 2025 Feb;
PMID: 39965885
Aims: Triple-negative breast cancer (TNBC) is prognostically and therapeutically heterogeneous. The mitotic activity index (MAI) and fibrotic focus (FF) have been established as predictors in non-TNBC but not in TNBC....
10.